Press Releases

 Filter by Provider

Corporación América Airports S.A. (NYSE: CAAP), (“CAAP” or the “Company”) one of the leading private airport operators in the world, reported today its unaudited, consolidated results for the three-month period ended March 31, 2026. Financial results are expressed in millions of U.S. dollars and are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”).

BOCA RATON, Fla., May 13, 2026 (SEND2PRESS NEWSWIRE) -- Web Scribble, a leading provider of career center technology for associations and mission-driven organizations, today announced the launch of Career Center technology for colleges and universities. The new offering helps institutions connect students earlier to employers, mentors, alumni, professional communities, career fairs, and long-term career pathways in one student-centered experience.

First Boric Acid Offtake Agreement Signed, Specialty Product Development and Financing Efforts Advance

DENVER, CO / ACCESS Newswire / May 13, 2026 / Solitario Resources Corp. ("Solitario" or the "Company") (NYSE American:XPL)( TSX:SLR) is pleased to announce the purchase and sale of 305,195 shares (the "Shares") of Company common stock, at a price of $0.77 per share for total gross proceeds of US$235,000 (the "Sale"). The Sale was made under the terms of the Amended and Restated Investor Rights Agreement dated June 11, 2025 (the "IRA") between Solitario and Newmont Overseas Exploration Ltd. ("Newmont"), a wholly owned subsidiary of Newmont Corporation. Newmont chose to exercise a right to acquire the Shares as permitted by the IRA at the average price of shares sold through Solitario's at-the-market program sales from Nov. 13, 2025, through April 6, 2026.

DENVER, CO / ACCESS Newswire / May 13, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today confirmed the next phase of expansion across the AimwellBio verified intelligence platform: new indication coverage, an expanding founding contributor cohort that now includes Doctors of Chiropractic alongside MDs and biopharma researchers, and a publicly requested signal roadmap pointing toward the four neurodegenerative categories the market has been waiting on someone credible to track.

WOBURN, MA / ACCESS Newswire / May 13, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, announced today that it will release its financial results for the second quarter of fiscal 2026 after market close on Thursday, May 14, 2026.

Rebrand reflects expanded commitment to military, with expansion from compression wear into custom orthotics for active-duty service members.

Canadians under 40 are adopting cashback 2.5 times faster than those aged 40+Cashback transactions increased 97 per cent across all...

Drill hole PL-118 intersected wide intervals of gold, silver, copper and zinc:Interval mAu g/tAg g/tCu %Zn %9.70.6221.280.472.5110.50.309.190.452.5213.10.5817.230.333.1229.61.249.880.801.5922.50.142.37 0.530.0341.50.04 1.85 0.390.03...

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Forge Resources Corp. (CSE: FRG) (OTCQB: FRGGF) (FSE: 5YZ) ("FRG" or...

CDW Corporation (Nasdaq: CDW) announced today that its Board of Directors has authorized a $1 billion increase to the Company’s share repurchase program.

Epineuron, a medical device company pioneering bioelectronic medicine, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Evala® Nerve Stimulator. This handheld, intraoperative electrical stimulation device is engineered to provide surgeons with a rapid and accurate solution for nerve identification and functional evaluation of different nerve sizes, large and small. This milestone marks a significant expansion of the company’s portfolio and commercial footprint of its proprietary bioelectronic platform for peripheral nerve care.

Eyelit Technologies (Eyelit), a leader in optimized planning, scheduling, and execution systems for manufacturers, today announced strong year-over-year growth in new bookings for 2025, highlighting continued momentum and increasing market demand for the company’s solutions.

Gilead Sciences, Inc. (Nasdaq: GILD) will present findings from 29 abstracts, including late-breaking presentations at the European Association for the Study of the Liver (EASL) Congress, May 27-30, 2026, Barcelona. These presentations advance understanding of primary biliary cholangitis (PBC) and viral hepatitis.

Federal Pacific today announced a large contract award from Bloom Energy to supply medium-voltage switchgear and engineering services supporting a large-scale AI data center project. Federal Pacific is one of America's largest manufacturers of medium-voltage switchgear and power distribution equipment.

PSQ Holdings, Inc. (NYSE: PSQH), a payments and financial infrastructure company purpose-built to serve merchants in both underserved and highly regulated markets, today issued a statement welcoming the Office of the Comptroller of the Currency’s (OCC) new public guidance on reporting prohibited debanking policies. The guidance advances the implementation of President Trump’s Executive Order 14331, Guaranteeing Fair Banking for All Americans, and provides both businesses and consumers with a formal mechanism to document politicized debanking. These reports, the OCC notes, will be considered in bank licensing and Community Reinvestment Act reviews, providing an important enforcement and self-policing mechanism for banks.

MFS® Investment Grade Municipal Trust (the “Fund”) (NYSE: CXH) announced today that its tender offer for 4,099,610 shares of the Fund’s outstanding common shares (the “Shares”), representing approximately 50% of the Fund’s outstanding shares, expired at 5:00 P.M., Eastern Time, on May 12, 2026.

Global Payments Inc. (NYSE: GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today unveiled an AI-first Genius™ handheld designed for both the physical demands of frontline environments and AI advances that are transforming how businesses run. Sleek and rugged, the ultra-thin handheld slips easily into standard aprons and pockets while delivering the capability to seamlessly communicate with intelligent agents that can help drive faster, smarter operations.

OSI Systems, Inc. (NASDAQ: OSIS) today announced that management will participate in the BofA Securities 33rd Annual Industrials, Transportation & Airlines Key Leaders Conference on Thursday, May 14, 2026, in New York, NY. The presentation is scheduled for 10:20 a.m. EDT.

CitroTech Inc. (NYSE AM: CITR), a leading specialty chemicals company producing environmentally responsible fire inhibitor solutions, and the Texas A&M Engineering Experiment Station (TEES), the official research agency of the Texas A&M University College of Engineering, today announced a 12-month research partnership to develop next-generation, water-based polymer technologies for fire-resistant textiles.

Mann Partners today announced the appointment of David Cohen, Partner and Managing Director at Kelso & Company, to its Advisory Board. The appointment strengthens the firm’s private equity and human capital expertise as organizations confront increasingly complex operating model, talent, and growth challenges.

As enterprises push AI beyond pilots and into production, a new challenge is emerging: most data foundations were never built for AI. Starburst, a leading enterprise intelligence platform, today announced it will host its annual AI & Datanova conference May 27-28, 2026 in Miami Beach, Florida and online. AI & Datanova 2026 will bring together enterprises and technology innovators to explore how AI is deployed in enterprise environments.

Talica is pleased to announce the acquisition of Sieber Industrial, an Ayden, North Carolina based provider of specialty high purity fabrication, ASME code repairs, surface treatments, and field services supporting biotech, pharmaceutical, data center, and other highly regulated and mission critical markets.

UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced the launch of an AI-powered ULTRUS UL 360 software capability designed to help organizations calculate product carbon footprints and improve the quality of supplier emissions data used in carbon accounting and reporting.

Finback Investment Partners ("Finback" or the "Firm") announced today the successful close of its second private equity fund, Finback Investment Partners 2024 Fund, LP (the "Fund"). The Fund was oversubscribed and closed with nearly $500 million in capital commitments, reflecting continued demand from both new and existing limited partners for the Firm's strategic value-add investment approach.

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods is intensifying. MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) (profile) is taking a distinctive approach: harnessing artificial intelligence (AI) and voice analysis to predict impairment from brief speech recordings. By treating the human voice as a window into underlying physiological and cognitive states, MindBio is focused on building a platform capable of detecting intoxication across a wide variety of substances in real-time. This approach addresses a meaningful gap in existing detection technology and reflects a larger move toward AI-powered, noninvasive diagnostics with the potential to reshape how enforcement, employers and health systems identify and respond to impairment. MindBio is part of a broader group of companies working at the crossroads of health and AI, including Spectral AI Inc. (NASDAQ: MDAI), Nano-X Imaging Ltd. (NASDAQ: NNOX), NVIDIA Corporation (NASDAQ: NVDA) and Caris Life Sciences Inc. (NASDAQ: CAI).

Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, Mailchimp, and Intuit Enterprise Suite, today announced several enhancements to Intuit Enterprise Suite, providing mid-market businesses with a command center that delivers AI-powered, real-time insights, automates complex financial management processes, and fully integrates Human Capital Management operations and money transactions in one place so they can save time and make faster, more profitable decisions.

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world today, contributing to surging rates of cardiovascular disease, fatty liver disease, kidney complications and ballooning healthcare expenses. What once represented a specialized class of diabetes treatments has grown into one of the most consequential therapeutic categories in modern medicine, with GLP-1 receptor agonists now fundamentally restructuring how obesity, metabolic disease and potentially even neurodegeneration are treated. Operating in this environment is SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (profile), which through its subsidiary GlucaPharm Inc. is developing a distinct next-generation GLP-1 platform built around GEP-44, a novel triple agonist peptide engineered to improve efficacy, tolerability, and delivery flexibility within one of the most commercially dynamic pharmaceutical markets in history. SureNano is one of the emerging microcap companies active in the GLP-1 space, operating alongside established leaders including Merck & Co. Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Viking Therapeutics Inc. (NASDAQ: VKTX) and Altimmune Inc. (NASDAQ: ALT).

RECLAIM – LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis, on schedule to initiate in the 2nd half of 2026

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The nature of modern conflict is being fundamentally rewritten, driven by the explosive proliferation of cheap, mass-produced drones that are upending the economics of warfare. In war-torn settings such as Ukraine, millions of low-cost systems, often assembled in small workshops or adapted from off-the-shelf commercial hardware, are now performing functions once only sophisticated aircraft and expensive precision munitions could do. However, while drone hardware has grown abundant and affordable, a glaring constraint has surfaced: The vast majority of these systems lack the intelligence needed to operate independently in contested environments. GPS jamming, electronic warfare and the continuous requirement for human control expose a widening gap between what drones are capable of and what they need to be capable of to remain operationally relevant at scale. Defense leaders are realizing that the next chapter of this revolution will not be written by better hardware alone but by better software, the intelligence layer that delivers autonomy, navigation and targeting precision without depending on systems that adversaries have learned to disrupt. SPARC AI Inc. (OTC: SPAIF) (profile) is operating within this space, creating a software-only platform meant to equip any drone, regardless of cost or manufacturer, with GPS-denied navigation and precision targeting capability. SPARC AI operates alongside a broader cohort of companies active in the drone, AI, and defense-tech space, including Swarmer Inc. (NASDAQ: SWMR), Unusual Machines (NYSE American: UMAC), Draganfly Inc. (NASDAQ: DPRO) and Red Cat Holdings Inc. (NASDAQ: RCAT).

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) (“PharmAla” or the “Company”), a leader in the research, development, and manufacturing of clinical-grade MDMA and novel MDXX-class compounds, today announced that it has executed a definitive SPV Formation, Shareholder and License Agreement (the “Definitive Agreement”) with Aluvaris Inc. (“Aluvaris”) and Diteba Inc. (“Diteba”). The Definitive Agreement establishes a jointly-owned special purpose vehicle called Restora Neurosciences (the “Restora” or the “SPV”) to lead the clinical and regulatory development of APA-01, the Company’s patented novel MDXX molecule, with the explicit objective of filing a first Investigational New Drug application with the U.S. Food and Drug Administration.

Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27

TOLEDO, Ohio, May 13, 2026 (GLOBE NEWSWIRE) -- EpicQuest Education Group International Limited (Nasdaq: EEIQ), (“EpicQuest Education”, “EEIQ” or the “Company”), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced a Letter to Shareholders from its Chairman and CEO.

BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that, effective May 8, 2026, it awarded an inducement grant to Christopher Sarchi under Bicara’s 2026 Inducement Plan as a material inducement to his commencement of employment as Bicara’s Chief Commercial Officer.

Lite Strategy Continues to Deliver Recurring Yield on Litecoin Holdings and Advance Share Repurchase Program

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Among the most guarded structures in human biology, the brain is also one of the hardest to treat. The blood-brain barrier (BBB), a specialized biological membrane, shields neural tissue from foreign substances, including most therapeutic agents. As cases of Alzheimer's disease climb worldwide and governments sharpen their focus on biodefense, the absence of efficient pathways for delivering drugs to the brain is fast becoming one of medicine's most pressing unresolved problems. Companies such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile) are responding to this challenge with next-generation delivery platforms engineered to circumvent biological barriers and ensure direct, targeted access to the central nervous system (CNS). Oncotelic has developed a proprietary intranasal nose-to-brain (N2B) system capable of rapidly shuttling therapeutics to the brain, a signal of growing industry consensus that delivery innovation, not merely drug discovery, will drive the next wave of breakthroughs in CNS medicine. Oncotelic joins a group of leading biopharma companies working in the biopharmaceutical and advanced therapeutics space, including Amgen Inc. (NASDAQ: AMGN), Johnson & Johnson (NYSE: JNJ), AbbVie Inc. (NYSE: ABBV) and Lunai Bioworks Inc. (NASDAQ: LNAI).

The Company’s first Eos-spec magnet reliably reached the magnetic fields and electrical currents required to create power plant-relevant, steady-state fusion in its upcoming “Eos” stellarator

ValueSelling Associates has been named to the Selling Power annual list of Top Sales Training Companies for 2026, marking its 13th consecutive year of recognition. This honor highlights the company’s continued innovation in value-based sales methodology and its industry leading AI enabled coaching solutions.

BOCA RATON, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) (“NewtekOne” or the “Company”) announced that it will participate in three conferences in the second half of May. Those conferences are LD Micro Invitational XVI May 17-19 in Los Angeles, B. Riley Securities 26th Annual Investor Conference May 20-21 in Los Angeles, and Centurion One Capital Miami Summit May 26-28 in Miami.

Company reports 48% reduction in combined Scope 1 and Scope 2 emissions since 2022, matches 74% of electricity consumption with renewable sources

A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapy

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Glenstar Minerals Inc. (CSE: GSTR) (OTCQB: GSTRF) (FSE: VO20) ("Glenstar" or...

With reference to the annual general meeting in Equinor ASA (OSE: EQNR, NYSE:EQNR) held on 12 May 2026 and the stock exchange announcement of the same date. The minutes are now finalised and enclosed hereto.

A strong essay does not need fancy language or complicated arguments to earn a good score. It needs clarity, structure, evidence, and control. Most students lose marks not because they have no ideas, but because those ideas are buried under weak organization, vague claims, rushed editing, or poor use of sources.

Concacaf today announced the launch of a new website and mobile app experience deployed using Deltatre's award-winning technology, establishing a single digital destination for football fans across the confederation's 41 Member Associations.

Lexitas donates $25,000 in 2026 as CEO Nishat Mehta and employees participate in Guardian Revival 5K

LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) announces that it is scheduled to participate in a series of energy, critical-minerals, battery-supply-chain and investor conferences during May and June 2026. In connection with these events, the Company has also updated its corporate presentation, available on its website, to reflect recent announcements and ongoing progress at its field operations in Howard County, Texas.

QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three months ended March 31, 2026 and provided a business update.

Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification and fraud prevention, announced today that its Mitek Verified Identity Platform® (MiVIP) is now available on FICO® Marketplace, the industry’s first marketplace for composable enterprise decisioning offerings. The listing empowers enterprises to operationalize AI and drive better outcomes by easily discovering, accessing, and deploying a wide range of pre-built offerings, including AI models, data services and analytics. This addresses a critical need in the industry for organizations to leverage cutting edge technology while preserving their ability to work across their organization to bring together teams and differentiate their business with their own unique intellectual property and customer experiences.

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Cal-Maine Foods, Inc. (NASDAQ: CALM) failed to manage Cal-Maine Foods in an acceptable manner, breaching their fiduciary duties to Cal-Maine Foods, and whether Cal-Maine Foods and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: